GoHealth, Inc. (NASDAQ:GOCO – Free Report) – Stock analysts at Sidoti Csr issued their Q1 2026 earnings per share estimates for shares of GoHealth in a research report issued to clients and investors on Wednesday, January 8th. Sidoti Csr analyst J. Sidoti forecasts that the company will post earnings of ($0.65) per share for the quarter. The consensus estimate for GoHealth’s current full-year earnings is ($5.50) per share. Sidoti Csr also issued estimates for GoHealth’s Q2 2026 earnings at ($2.73) EPS, Q3 2026 earnings at ($3.41) EPS and Q4 2026 earnings at ($2.04) EPS.
Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $13.00 price target on shares of GoHealth in a research report on Monday, October 21st.
GoHealth Trading Up 0.3 %
Shares of GOCO stock opened at $14.71 on Friday. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.18 and a current ratio of 1.18. GoHealth has a 1 year low of $7.27 and a 1 year high of $14.99. The stock has a fifty day moving average of $12.43 and a two-hundred day moving average of $10.94. The firm has a market capitalization of $336.95 million, a PE ratio of -4.20 and a beta of 1.64.
Institutional Trading of GoHealth
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Geode Capital Management LLC raised its stake in shares of GoHealth by 3.2% in the 3rd quarter. Geode Capital Management LLC now owns 103,735 shares of the company’s stock worth $973,000 after buying an additional 3,205 shares in the last quarter. Empowered Funds LLC raised its stake in shares of GoHealth by 5.1% in the 3rd quarter. Empowered Funds LLC now owns 22,048 shares of the company’s stock worth $207,000 after buying an additional 1,072 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of GoHealth by 22.0% in the 2nd quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock worth $178,000 after buying an additional 3,300 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of GoHealth by 16.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 12,982 shares of the company’s stock worth $126,000 after buying an additional 1,802 shares in the last quarter. Finally, Barclays PLC raised its stake in shares of GoHealth by 83.9% in the 3rd quarter. Barclays PLC now owns 9,580 shares of the company’s stock worth $89,000 after buying an additional 4,372 shares in the last quarter. Institutional investors own 24.21% of the company’s stock.
About GoHealth
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
See Also
- Five stocks we like better than GoHealth
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- 3 Stocks to Consider Buying in October
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.